Cargando…
Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
A variety of autoimmune disorders have been reported after viral illnesses and specific vaccinations. Cases of de novo immune thrombocytopenia (ITP) have been reported after SARS-CoV-2 vaccination, although its effect on preexisting ITP has not been well characterized. In addition, although COVID-19...
Autores principales: | Portuguese, Andrew Jay, Sunga, Cassandra, Kruse-Jarres, Rebecca, Gernsheimer, Terry, Abkowitz, Janis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8276576/ https://www.ncbi.nlm.nih.gov/pubmed/34255033 http://dx.doi.org/10.1182/bloodadvances.2021004957 |
Ejemplares similares
-
Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
por: Salhi, Sofiane, et al.
Publicado: (2020) -
MPO-ANCA-associated vasculitis after the Pfizer/BioNTech SARS-CoV-2 vaccination
por: Obata, Shota, et al.
Publicado: (2021) -
Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine
por: Unver, Suat, et al.
Publicado: (2021) -
Dobrava hantavirus and coinciding SARS-CoV-2 infection mimicking thrombotic microangiopathy and responding to a single dose of eculizumab
por: Aberger, Simon, et al.
Publicado: (2023) -
COVID-19 convalescent plasma clears SARS-CoV-2 refractory to remdesivir in an infant with congenital heart disease
por: Rodriguez, Zahidee, et al.
Publicado: (2020)